Compare Amphastar Pharmaceuticals Inc (AMPH) vs Peloton Interactive Inc (PTON) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Amphastar Pharmaceuticals Inc vs Peloton Interactive Inc — how do they compare? Amphastar Pharmaceuticals Inc trades at $20.39 (market cap $863.95M), while Peloton Interactive Inc trades at $5.6 (market cap $2.42B). The key difference: Peloton Interactive Inc is far larger — about 2.8× Amphastar Pharmaceuticals Inc's market cap, and Peloton Interactive Inc is trading nearer its 52-week high, Amphastar Pharmaceuticals Inc nearer its low. Which is the better fit depends on your goals.
| AMPH | PTON | |
|---|---|---|
Market Cap | $863.95M | $2.42B |
Sector | Health | Consumer Cyclical |
52-Week High | $30.81 | $9.00 |
52-Week Low | $16.87 | $3.71 |
Enterprise Value | $1.26B | $2.92B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AMPH trades at $20.78, up 4.9% today, with a bullish technical signal supported by moving averages. The stock shows mixed earnings performance with Q2 2026 beating estimates but Q1 and Q4 2025 missing. Fundamentals remain solid with a 10.76% net margin and reasonable valuation at 12.02 P/E. Recent news highlights Q2 2026 results and strategic shift toward proprietary drugs.
Outlook is cautiously optimistic with growth supported by new product launches, though regulatory risks and earnings volatility pose challenges. Analyst sentiment is mixed with 25% buy ratings but majority hold recommendations. The stock offers value but requires monitoring of FDA developments and earnings consistency.
Peloton Interactive (PTON) trades at $5.68, up 3.18% with a bearish technical signal despite recent earnings beat. The company achieved its first annual net profit in fiscal 2026 with $63M net income, though revenue declined to $2.4B. Valuation metrics show a P/E of 40.54 and P/S of 1.01, while negative shareholder equity of -$413.7M reflects historical losses. Recent news highlights profitability progress but concerns about subscriber declines and conservative 2027 guidance.
PTON presents a turnaround story with improving profitability but faces significant revenue headwinds. The stock offers potential upside if subscriber stabilization occurs, though high debt levels and competitive pressures pose substantial risks. Analyst consensus is divided with 50% buy ratings, suggesting cautious optimism amid ongoing business transformation challenges.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Amphastar Pharmaceuticals Inc
Amphastar is a specialty pharmaceutical company that develops and markets injectable, intranasal, and inhalation products. Its portfolio includes both complex generic drugs and proprietary delivery systems.
Read more on AMPH →About Peloton Interactive Inc
Peloton Interactive Inc operates an interactive fitness platform. It operates its business in two reportable segments: Connected Fitness Products and Subscription. Connected Fitness Product revenue consists of sales of bike and tread and related accessories, associated fees for delivery and installation, and extended warranty agreements. Subscription revenue consists of revenue generated from monthly Connected Fitness Subscription and Digital Subscription. The company generates the majority of the revenue from the sale of Connected Fitness Products.
Read more on PTON →
